University of California San Diego
San Diego, California, 92103, United States
NCT Number: NCT01609322
This project aims to test the efficacy of an in-home intervention, "Activity, Balance, Learning, and Exposure" (ABLE), which integrates exposure therapy with cognitive restructuring, exercise, and home safety evaluation for older adults with excessive fear of falling. The intervention will be conducted by a licensed physical therapist. A control intervention will be conducted by a health educator. The specific aims of the study are to test the feasibility, acceptability, tolerability, and safety of the ABLE intervention.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Phase 2
San Diego, California, 92103, United States
Approximately 7-14% of older adults living independently in the community, including more than 5% of those who have never experienced a fall, experience moderate to severe fear of falling. Fear of falling leads to decreased physical activity, disability, loss of independence, depression, anxiety, reduced social engagement, and poor quality of life. It is also a major independent risk factor for falls.
Interventions targeting fear of falling, typically delivered in groups and incorporating cognitive restructuring, education, and exercise, have been shown to increase fall-related self-efficacy. Avoidance is resistant to treatment, however, and more than one-third of patients enrolled in these interventions drop out. Factors associated with attrition include high levels of fear and avoidance, indicating that the individuals most in need of such programs are those most likely to withdraw prematurely. These data suggest that avoidance should be targeted in treatment, and that interventions should be designed to reach very fearful individuals who are most likely to drop out of traditional fear of falling programs.
Participation in this study will last up to 8 months. Participants will be randomly assigned to receive either the ABLE intervention or an education control condition. The control condition will consist of in-person education about falls to control for the time and attention provided in the ABLE arm.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An in-home intervention that integrates exposure therapy with cognitive restructuring, exercise, and a home safety evaluation.
In-home, individual sessions with a health educator regarding fall prevention
Time frame: 2 months (primary)
Fear of Falling will be measured using the Falls Efficacy Scale - International (FES-I), a version of the most widely used measure of falls self-efficacy. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point). We will also collect data at 5 months (3 month follow-up) and 8 months (6 month follow-up).
Time frame: 2 months (primary)
Activity avoidance will be assessed using a modified version of the Activity Card Sort, a set of photographs of older adults engaged in various activities that is used in rehabilitation settings. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point), 5 months (3 month follow-up), and 8 months (6 month follow-up).
Time frame: 2 months (primary)
Self-reported physical activity will be assessed with the Physical Activities Scale for the Elderly (PASE).
Time frame: 2 months
Accelerometers will also be used to measure physical activity. Patients in the study will wear an Actigraph battery-operated activity monitor worn around the waist to measure physical activity continuously during waking hours. Assessment will occur before and after the intervention.
Time frame: 2 months (primary)
Physical performance will be measured using the Short Physical Performance Battery (SPPB), which includes measured of balance, walking, and lower body strength.
Time frame: 2 months (primary)
Quality of life will be measured with the Quality of Life Inventory (QOLI).
Time frame: 2 months (primary)
Depressive and anxiety symptoms will be assessed with the Hospital Anxiety and Depression Scale (HADS), a 14-item self-report measure with subscales assessing depressive and anxiety symptoms that does not include somatic items such as fatigue that can be associated with aging or medical conditions rather than psychiatric disorders.
Time frame: 2 months (primary)
Agoraphobic avoidance will be measured using the 5-item agoraphobia subscale of the Fear Questionaire (FQ).
Time frame: 2 months (primary)
Post Traumatic Stress Disorder (PTSD) symptoms will be measured with the 6-item abbreviated form of the PTSD Checklist (PCL).
Time frame: 2 months (primary)
Fear of falling will be measured using the Falling Questionaire, a 15-item survey assessing attitudes towards falling.
Time frame: 2 months (primary)
Avoidance of activities will be measured using the Fear of Falling Avoidance-Behavior Questionaire (FFABQ), a 14-item measure to assess avoidance behaviors.
Time frame: 2 months (primary)
Recorded on fall diaries provided to investigators throughout the 2-month intervention and 6-month follow-up period.
University of California, San Diego
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07327645
Basal Ganglia Diseases, Brain Diseases
Denizli, Kınıklı, Turkey (Türkiye)
View Trial DetailsNCT05889910
Falls, Fear of Falling
Getafe, Madrid, Spain
View Trial DetailsNCT07023718
Ankylosis, Fear of Falling
Brie-Comte-Robert, Île-de-France Region, France
View Trial DetailsNCT05406323
Fall, Fall Risk
Istanbul, Turkey (Türkiye)
View Trial Details